Professor of Endocrinology & Director Clinician PhD Programme & Clinical Research Facility, University of Cambridge
Sesión: “Nuevos Conocimientos sobre la Acción de la Hormona Tiroidea”
Full Professor. Head of the Louvain Drug Research Institute at the Université catholique de Louvain (Uclouvain, Belgium). Pionner in the Discovery of how prebiotic nutrients target the gut microbiota to improve health.
Sesión: “Microbioma”
Gerard Karsenty is Paul A. Marks M.D., Professor, and Chair of the Department of Genetics and Development at Columbia University in New York City. His research focuses on all aspects of skeletal biology. Dr. Gerard Karsenty identified the master gene of bone formation and hypothesized that there must be a coordinated regulation of bone mass energy metabolism and reproduction. Exploring all aspects of this overarching hypothesis allowed him to reveal the existence of central control of bone mass and the endocrine nature of bone. Currently, his work focuses on identifying and deciphering all the functions of a bone hormone his laboratory discovered, osteocalcin.
Sesión: “¿Conversaciones entre el hueso y el síndrome metabólico?”
Plenary Professor of Molecular Biology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. Superior Investigator of CONICET.
Sesión: “Regulación de la Transcripción Alternativa de ADN: un Gen, Muchas Proteínas.”
Professor, Karolinska Insitutet, Stockholm
Sesión: “Mecanismos moleculares de la resistencia a la insulina”
Professor Peter Rossing head of diabetes complications research at Steno Diabetes Center Copenhagen and professor endocrinology University of Copenhagen
Sesión: “Medicina Personalizada en la Diabetes Mellitus”
Plenary Professor of Molecular Biology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. Superior Investigator of CONICET.
Sesión: “El Uso de la Genómica y la Inteligencia de Datos para Comprender y Tratar las Enfermedades Endócrinas”
Professor Alfredo Ulloa-Aguirre, Scientific Director, Research Support Network (RAI), National University of Mexico UNAM)-National Institutes of Health, Mexico City
Sesión: “Desvío de ruta de los receptores a proteína G y enfermedad endocrina. Mecanismos moleculares y perspectivas terapéuticas.”
Brian Walker is Chair of Medicine and Pro Vice Chancellor for Research Strategy & Resources at Newcastle University, UK. Until 2017, he was Professor of Endocrinology and Head of the BHF Centre for Cardiovascular Science at the University of Edinburgh, UK. A clinical Endocrinologist, his research over >25 years – spanning rodent models, experimental medicine, drug discovery, and genetic epidemiology – has systematically documented the contributions of glucocorticoids to cardiovascular disease risk, identified novel determinants of tissue glucocorticoid action, and targeted these with new drugs.
Sesión: “Control del Cortisol en la enfermedad cardiometabólica”
Dr. Corrine Welt
Professor of Medicine Chief of Endocrinology
Metabolism and Diabetes
University of Utah
Sesión: “Relevancia de los estudios genéticos en la comprensión de la físiopatologia del SOP”